title: Characterization, treatment, and outcome of bacterial cholecystitis and bactibilia in dogs.
abstract: Objective-To characterize historical, clinicopathologic, ultrasonographic, microbiological, surgical, and histopathologic features of bacterial cholecystitis and bactibilia in dogs and evaluate response to treatment and outcomes in these patients. Design-Retrospective case-control study. Animals-40 client-owned dogs (10 with bacterial cholecystitis on histologic analysis or bactibilia on cytologic examination [case dogs] and 30 without bactibilia [controls]) evaluated at a veterinary teaching hospital between 2010 and 2014. Procedures-Signalment, history, clinicopathologic findings, ultrasonographic features, microbiological results, surgical findings, histopathologic changes, treatments, and outcomes of case dogs were derived from medical records and summarized. Demographic and clinicopathologic data and ultrasonographic findings were compared between case and control dogs. Relationships among prior antimicrobial treatment, sediment formation in the gallbladder, presence of immobile biliary sludge, and presence of bactibilia or bacterial cholecystitis were assessed. Results-No finding was pathognomonic for bactibilia or bacterial cholecystitis in dogs. Case dogs were significantly more likely to have immobile biliary sludge and had a greater degree of biliary sediment formation than did control dogs. All case dogs for which gallbladders were examined histologically (6/6) had bacterial cholecystitis. Five of 10 case dogs were Dachshunds. Medical or surgical treatment resulted in good outcomes. Conclusions and Clinical Relevance-Bactibilia and bacterial cholecystitis were important differential diagnoses in dogs with signs referable to biliary tract disease. Dachshunds were overrepresented, which may suggest a breed predisposition. Cytologic evaluation of bile should be considered in the routine assessment of dogs with hepatobiliary disease if immobile biliary sludge is present. (J Am Vet Med Assoc 2015;246:982-989).
authors: Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331.
authors: Yuri A
authors: YA
authors: Lawrence
authors: Craig G
authors: CG
authors: Ruaux
authors: Sarah
authors: S
authors: Nemanic
authors: Milan
authors: M
authors: Milovancev
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D001646:Bile / Q000382:microbiology*; D016022:Case-Control Studies; D002756:Cholagogues and Choleretics / Q000008:administration & dosage / Q000627:therapeutic use; D002764:Cholecystitis / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery / Q000662:veterinary*; D004283:Dog Diseases / Q000382:microbiology* / Q000628:therapy; D004285:Dogs; D005260:Female; D008297:Male; D012189:Retrospective Studies; D016896:Treatment Outcome; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid